Stem Cell-Based Approaches in Parkinson's Disease Research

被引：3

作者：

Kim, Min Seong ^{[1
,2
,9
]}

Yoon, Subeen ^{[3
]}

Choi, Jiwoo ^{[3
]}

Kim, Yong Jun ^{[3
,4
,5
,8
]}

Lee, Gabsang ^{[1
,2
,6
,7
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA

[2] Johns Hopkins Univ, Sch Med, Dept Neurol, 733 N Broadway, Baltimore, MD 21218 USA

[3] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, 26 Kyungheedae-ro,Dongdaemun-gu, Seoul 02447, South Korea

[4] Kyung Hee Univ, Coll Med, Dept Pathol, Seoul, South Korea

[5] Kyung Hee Univ, Grad Sch, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea

[6] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA

[7] Johns Hopkins Univ, Sch Med, Dept Neurol, 733 N Broadway, Baltimore, MD 21205 USA

[8] Kyung Hee Univ, Coll Med, Dept Pathol, 26 Kyungheedae, Seoul 02447, South Korea

[9] Sejong Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF STEM CELLS | 2024年

基金：

新加坡国家研究基金会;

关键词：

Disease model; Parkinson disease; Stem cell therapy; Pathological mechanism; MIDBRAIN DOPAMINERGIC-NEURONS; PATHOLOGICAL ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; NEURAL STEM; FAMILIAL DYSAUTONOMIA; PROGENITOR CELLS; LYSOSOMAL DYSFUNCTION; BRAIN ORGANOIDS; IN-VIVO; LRRK2;

D O I：

10.15283/ijsc23169

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of midbrain dopaminergic neurons, leading to motor symptoms. While current treatments provide limited relief, they don't alter disease progression. Stem cell technology, involving patient-specific stem cell-derived neurons, offers a promising avenue for research and personalized regenerative therapies. This article reviews the potential of stem cell -based research in PD, summarizing ongoing efforts, their limitations, and introducing innovative research models. The integration of stem cell technology and advanced models promises to enhance our understanding and treatment strategies for PD.

引用

页数：16

共 50 条

[31] Cell-based therapy for Parkinson disease
Lozano, Andres M.
NEUROSURGICAL FOCUS, 2008, 24 (3-4)
[32] The science and ethics of cell-based therapies for Parkinson's disease
Towns, C. R.
PARKINSONISM & RELATED DISORDERS, 2017, 34 : 1 - 6
[33] Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells
Bagheri-Mohammadi, Saeid
Karimian, Mohammad
Alani, Behrang
Verdi, Javad
Tehrani, Rana Moradian
Noureddini, Mahdi
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) : 1326 - 1335
[34] Stem Cell-Based Approaches for the Treatment of Diabetes
Kelly, Catriona
Flatt, Cara C. S.
McClenaghan, Neville H.
STEM CELLS INTERNATIONAL, 2011, 2011
[35] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease
Grow, Douglas A.
McCarrey, John R.
Navara, Christopher S.
STEM CELL RESEARCH, 2016, 17 (02) : 352 - 366
[36] Manufacturing MSK-DA01: a human embryonic stem cell-based cell therapy for Parkinson's disease
Zabierowski, S.
Hill, E.
Dubose, B.
Wang, Y.
Tabar, V.
Henchcliffe, C.
Studer, L.
Riviere, I.
Irion, S.
Tomishima, M.
HUMAN GENE THERAPY, 2016, 27 (11) : A158 - A159
[37] Cell-Based Therapies for Parkinson's Disease: Past, Present, and Future
Fitzpatrick, Kathleen M.
Raschke, James
Emborg, Marina E.
ANTIOXIDANTS & REDOX SIGNALING, 2009, 11 (09) : 2189 - 2208
[38] The challenges of administering cell-based therapies to patients with Parkinson's disease
Drouin-Ouellet, Janelle
Barker, Roger A.
NEUROREPORT, 2013, 24 (18) : 1000 - 1004
[39] Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
Buttery, Philip C.
Barker, Roger A.
NEUROTHERAPEUTICS, 2020, 17 (04) : 1539 - 1562
[40] Development of stem cell-based therapies for Parkinson'sdisease
Zhu, Bangfu
Caldwell, Maeve
Song, Bing
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (11) : 955 - 962

← 1 2 3 4 5 →